VERTEX PHARMACEUTICALS INC / MA Restructuring Reserve, Settled without Cash (Deprecated 2016-01-31)
VERTEX PHARMACEUTICALS INC / MA (VRTX) reported Restructuring Reserve, Settled without Cash (Deprecated 2016-01-31) of -$7.59 million for the 12-month period ending 2013-12-31, per its 10-K filed 2014-02-11.
Discontinued › Notes › Restructuring and Related Activities
us-gaap:RestructuringReserveSettledWithoutCash1 · last filed 2014-02-11
- VERTEX PHARMACEUTICALS INC / MA restructuring reserve, settled without cash (deprecated 2016-01-31) for fiscal 2013 was -$7.59M.
- VERTEX PHARMACEUTICALS INC / MA restructuring reserve, settled without cash (deprecated 2016-01-31) for fiscal 2012 was $0.00.
- VERTEX PHARMACEUTICALS INC / MA restructuring reserve, settled without cash (deprecated 2016-01-31) for fiscal 2011 was $0.00.
| Period end | Restructuring Reserve, Settled without Cash (Deprecated 2016-01-31) 12 month |
|---|---|
| 2013-12-31 | -$7.59M 10-K · filed 2014-02-11 |
| 2012-12-31 | $0.00 10-K · filed 2014-02-11 |
| 2011-12-31 | $0.00 10-K · filed 2014-02-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |